A new poll from the Trafalgar Group reveals that former President Donald Trump is leading Kamala Harris in the key battleground state of Pennsylvania.
The survey, conducted between September 26 and 29, polled 1,090 registered voters in the state. The results show Trump leading Harris with 47.5 percent of the vote, compared to Harris’ 45.3 percent.
-
The Importance of Prayer: How a Christian Gold Company Stands Out by Defending Americans’ Retirement
The poll has a margin of error of +/- 2.9 percent, placing the two candidates in a virtual tie and making Pennsylvania a toss-up state for the 2024 election.
📊 PENNSYLVANIA GE: Trafalgar Group
🟥 Trump: 47.5% (+2.2)
🟦 Harris: 45.3%
🟪 Other: 2.6%
—
Senate
🟦 Casey (inc): 47.4% (+1.8)
🟥 McCormick: 45.6%
——
#279 (0.7/3.0) | 9/26-29 | LV | ±2.9%https://t.co/DxDxkIy08t pic.twitter.com/U9ivq4Prab— InteractivePolls (@IAPolls2022) September 29, 2024
Despite Trump’s narrow lead, Pennsylvania remains a difficult state to predict, especially given its history as a highly contested battleground in recent elections. […]
— Read More: www.rvmnews.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.